Alex

Biofuel Market Forecast to Reach $216.05 Billion by 2028 with Emerging Asia-Pacific Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Biofuel Market: Analysis by Consumption, Production, Type, Form, Feedstock, Region Size &…

Jiuxian Group: China’s No.1 Liquor Enterprise announced new year goal of revenue 100 Billion Yuan

BEIJING--(BUSINESS WIRE)--At the beginning of 2024, Jiuxian, number one liquor circulation enterprise in China, announced…

Komatsu and Williams Racing reignite historic partnership

NEW YORK--(BUSINESS WIRE)--Leading heavy equipment manufacturer Komatsu has signed a multi-year deal with Williams Racing…

Bay Community Bancorp Earns $1.31 Million in Fourth Quarter 2023 and a Record $8.23 Million for the Year; Declares Quarterly Cash Dividend of $0.05 Per Share

OAKLAND, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Bay Community Bancorp, (OTCPink: CBOBA) (the “Company”),…

New Consumer Survey Reveals How Pervasive Returns Fraud and Policy Abuse Are Among Australia Retail Shoppers

Nearly 4 in 10 respondents say that either they, or someone they know, has engaged…

AMTD IDEA Successfully Completed Its Share Repurchase Program

PARIS & NEW YORK & SINGAPORE--(BUSINESS WIRE)--AMTD IDEA Group (“AMTD IDEA” or “Company”, NYSE: AMTD;…

Forrester Opens Nominations For Its 2024 Global Technology Awards

Awards recognize organizations that align their IT strategy to their business goals to accelerate growth…

Cenntro Shareholders Vote in Favor of Proposed Scheme to Redomicile from Australia to the United States

FREEHOLD, N.J.--(BUSINESS WIRE)--Cenntro Electric Group Limited (NASDAQ: CENN) (“Cenntro”, or the “Company”), a leading electric…

Shionogi Strengthens Regulatory Leadership with the Appointment of Dr. Ramón Polo as Senior Vice President, Head of Regulatory Affairs

Dr. Polo Brings More than 30 Years of Global Regulatory Affairs and Drug Development Experience…

New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster

Study conducted by Meiji Seika Pharma in Japan Short communication follows previously published data in…